A Phase 1 Study of JNJ-95804306 for Relapsed or Refractory Hematological Malignancies

Status

Not yet recruiting

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2026-525234-39-00

Enrollment

Registered

2026-07-13

Start date

Unknown

Completion date

Unknown

Last updated

2026-07-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Relapsed or Refractory acute myeloid leukemia, Relapsed or Refractory chronic lymphocytic leukemia, Relapsed or Refractory higher-risk myelodysplastic syndromes, Relapsed or Refractory small lymphocytic lymphoma

Interventions

None listed

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Outcome results

None listed

Source: EU CTIS · Data processed: Jul 14, 2026

A Phase 1 Study of JNJ-95804306 for Relapsed or Refractory Hematological Malignancies

Conditions

Related papers

Interventions

Sponsors

Eligibility

Outcome results